Skip to main navigation
logo
  • Overview
  • News & Events
    • Press Releases
    • Calendar of Events
    • Presentations
  • Financial Info
    • SEC Filings
    • Supplemental Financial Information
  • Corporate Governance
    • Documents & Charters
    • Leadership
    • Board of Directors
    • Committee Composition
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • Investor Resources
    • FAQ
    • Information Requests
    • IR Contact

Lantheus and GE Healthcare Announce the Signing of a Definitive License Agreement for Worldwide Development and Commercialization of Flurpiridaz F 18

  • Read more about Lantheus and GE Healthcare Announce the Signing of a Definitive License Agreement for Worldwide Development and Commercialization of Flurpiridaz F 18

Lantheus Holdings to Host First Quarter 2017 Earnings Conference Call on May 2, 2017 at 4:30 p.m. Eastern Time

  • Read more about Lantheus Holdings to Host First Quarter 2017 Earnings Conference Call on May 2, 2017 at 4:30 p.m. Eastern Time

Lantheus Announces Refinancing of its Debt Facility

  • Read more about Lantheus Announces Refinancing of its Debt Facility

Lantheus Holdings, Inc. Announces Public Secondary Offering of 3,000,000 Shares of Common Stock by Selling Stockholders

  • Read more about Lantheus Holdings, Inc. Announces Public Secondary Offering of 3,000,000 Shares of Common Stock by Selling Stockholders

Lantheus Holdings, Inc. Reports 2016 Fourth Quarter and Full Year Financial Results; Provides 2017 Guidance

  • Read more about Lantheus Holdings, Inc. Reports 2016 Fourth Quarter and Full Year Financial Results; Provides 2017 Guidance

Lantheus Holdings and GE Healthcare Announce the Signing of a Term Sheet for Worldwide Development and Commercialization of Flurpiridaz F 18

  • Read more about Lantheus Holdings and GE Healthcare Announce the Signing of a Term Sheet for Worldwide Development and Commercialization of Flurpiridaz F 18

Lantheus Holdings to Host Fourth Quarter and Full Year 2016 Earnings Conference Call and Provide 2017 Guidance on February 21, 2017 at 4:30 p.m. Eastern Time

  • Read more about Lantheus Holdings to Host Fourth Quarter and Full Year 2016 Earnings Conference Call and Provide 2017 Guidance on February 21, 2017 at 4:30 p.m. Eastern Time

Lantheus Medical Imaging Announces FDA Approval of DEFINITY® Label Update

  • Read more about Lantheus Medical Imaging Announces FDA Approval of DEFINITY® Label Update

Lantheus Holdings Appoints New Member to its Board of Directors

  • Read more about Lantheus Holdings Appoints New Member to its Board of Directors

Lantheus Holdings, Inc. Announces Upsize of Public Offering to 3,500,000 Shares of Common Stock

  • Read more about Lantheus Holdings, Inc. Announces Upsize of Public Offering to 3,500,000 Shares of Common Stock

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 26
  • Page 27
  • Page 28
  • Page 29
  • Current page 30
  • Page 31
  • Page 32
  • Page 33
  • Page 34
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Site - Shareholder Services

Print Page
RSS Feeds
Email Alerts
  • Copyright © 2025 Lantheus Holdings, Inc. All rights reserved.